| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Preclinical Pharmacology |
Division of Experimental Therapeutics, Ontario Cancer Institute, University of Toronto, Toronto, Ontario, Canada M5G 2M9.
Penetration of anticancer agents to cells distant from the vascular system is required for efficacy of cancer chemotherapy against solid tumors. Many solid tumors have a poorly formed blood vascular system with variable rates of blood flow and much larger intercapillary distances than those found in normal tissues. The requirement for drugs to penetrate several layers of tissue might pose a barrier to the effective treatment of solid tumors. Multicellular layers (
200 µm thick) were grown in vitro on Teflon membranes from EMT6 murine and MCF7 human tumors and have been used to quantitate the penetration of four widely used anticancer drugs through solid tissue. The penetration of doxorubicin and mitoxantrone was limited and very slow (<10% of the rate of penetration through the Teflon membrane alone). The penetration of methotrexate and 5-FU was more rapid (30–50% of the rate of penetration through the Teflon membrane alone), but remains a substantial barrier to the effectiveness of these drugs. Strategies to improve the penetration of anticancer drugs through poorly vascularized tumor tissue have considerable potential to improve the outcome of chemotherapy for solid tumors.
This article has been cited by other articles:
|
|
 |
|
  O. Tredan, A. B. Garbens, A. S. Lalani, and I. F. Tannock The Hypoxia-Activated ProDrug AQ4N Penetrates Deeply in Tumor Tissues and Complements the Limited Distribution of Mitoxantrone Cancer Res., February 1, 2009; 69(3): 940 - 947. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Herrmann, W. Fayad, S. Schwarz, M. Berndtsson, and S. Linder Screening for Compounds That Induce Apoptosis of Cancer Cells Grown as Multicellular Spheroids J Biomol Screen, January 1, 2008; 13(1): 1 - 8. [Abstract] [PDF]
|
|
|
|
 |
|
 O. Tredan, C. M. Galmarini, K. Patel, and I. F. Tannock Drug Resistance and the Solid Tumor Microenvironment J Natl Cancer Inst, October 3, 2007; 99(19): 1441 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Grantab, S. Sivananthan, and I. F. Tannock The Penetration of Anticancer Drugs through Tumor Tissue as a Function of Cellular Adhesion and Packing Density of Tumor Cells Cancer Res., January 15, 2006; 66(2): 1033 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Primeau, A. Rendon, D. Hedley, L. Lilge, and I. F. Tannock The Distribution of the Anticancer Drug Doxorubicin in Relation to Blood Vessels in Solid Tumors Clin. Cancer Res., December 15, 2005; 11(24): 8782 - 8788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Li, L. Tian, J.-m. Hou, Z.-y. Ding, Q.-m. He, P. Feng, Y.-j. Wen, F. Xiao, B. Yao, R. Zhang, et al. Improved Therapeutic Effectiveness by Combining Recombinant CXC Chemokine Ligand 10 with Cisplatin in Solid Tumors Clin. Cancer Res., June 1, 2005; 11(11): 4217 - 4224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Khawli, P. Hu, and A. L. Epstein NHS76/PEP2, a Fully Human Vasopermeability-Enhancing Agent to Increase The Uptake and Efficacy of Cancer Chemotherapy Clin. Cancer Res., April 15, 2005; 11(8): 3084 - 3093. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. F. Tannock Limited Drug Access and Repopulation of Surviving Tumor Cells between Courses of Chemotherapy: Important and Neglected Causes of Clinical Drug Resistance Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 103 - 107. [Full Text] [PDF]
|
|
|
|
|
|
I. F. Tannock, C. M. Lee, J. K. Tunggal, D. S. M. Cowan, and M. J. Egorin Limited Penetration of Anticancer Drugs through Tumor Tissue: A Potential Cause of Resistance of Solid Tumors to Chemotherapy Clin. Cancer Res., March 1, 2002; 8(3): 878 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. O. Hicks, F. B. Pruijn, B. C. Baguley, and W. R. Wilson Extravascular Transport of the DNA Intercalator and Topoisomerase Poison N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide (DACA): Diffusion and Metabolism in Multicellular Layers of Tumor Cells J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1088 - 1098. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Sharma, D. White, A. R. Imondi, M. E. Placke, D. M. Vail, and M. G. Kris Development of Inhalational Agents for Oncologic Use J. Clin. Oncol., March 15, 2001; 19(6): 1839 - 1847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Frankel, S. Man, P. Elliott, J. Adams, and R. S. Kerbel Lack of Multicellular Drug Resistance Observed in Human Ovarian and Prostate Carcinoma Treated with the Proteasome Inhibitor PS-341 Clin. Cancer Res., September 1, 2000; 6(9): 3719 - 3728. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
